Vancomycin-associated DRESS demonstrates delay in AST abnormalities.


Journal

Archives of dermatological research
ISSN: 1432-069X
Titre abrégé: Arch Dermatol Res
Pays: Germany
ID NLM: 8000462

Informations de publication

Date de publication:
01 Nov 2024
Historique:
received: 11 09 2024
accepted: 17 10 2024
revised: 11 10 2024
medline: 1 11 2024
pubmed: 1 11 2024
entrez: 1 11 2024
Statut: epublish

Résumé

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a severe cutaneous adverse drug eruption characterized by rash, fever, lymphadenopathy, hematologic abnormalities, and organ dysfunction. Identifying causative agents and monitoring disease course in DRESS syndrome is crucial to prevent end-organ damage. The temporal relationship between causative medications including vancomycin and laboratory abnormalities in DRESS has not been studied, limiting the utility of laboratory data in monitoring disease course. Our study aims to investigate associations between medication class and peak serum laboratory values using simple linear regression (absolute eosinophils, creatinine, alanine aminotransferase [ALT] and aspartate aminotransferase [AST]). We found a significant difference between timing of peak AST values among vancomycin-triggered DRESS compared to other trigger groups. These findings draw attention to the increased role of AST as a diagnostic and monitoring tool in DRESS.

Identifiants

pubmed: 39485591
doi: 10.1007/s00403-024-03481-4
pii: 10.1007/s00403-024-03481-4
doi:

Substances chimiques

Vancomycin 6Q205EH1VU
Aspartate Aminotransferases EC 2.6.1.1
Alanine Transaminase EC 2.6.1.2
Anti-Bacterial Agents 0
Creatinine AYI8EX34EU

Types de publication

Journal Article Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

736

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Kardaun SH, Sekula P, Valeyrie-Allanore L et al (2013) Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol 169(5):1071–1080. https://doi.org/10.1111/bjd.12501
doi: 10.1111/bjd.12501 pubmed: 23855313
Madigan LM, Fox LP (2019) Vancomycin-associated drug-induced hypersensitivity syndrome. J Am Acad Dermatol 81(1):123–128. https://doi.org/10.1016/j.jaad.2019.02.002
doi: 10.1016/j.jaad.2019.02.002 pubmed: 30738120
Pannu AK, Saroch A (2017) Diagnostic criteria for drug rash and eosinophilia with systemic symptoms. J Family Med Prim Care 6(3):693–694. https://doi.org/10.4103/2249-4863.222050
doi: 10.4103/2249-4863.222050 pubmed: 29417040 pmcid: 5787987
Sharifzadeh S, Mohammadpour AH, Tavanaee A, Elyasi S (2021) Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review. Eur J Clin Pharmacol 77(3):275–289. https://doi.org/10.1007/s00228-020-03005-9
doi: 10.1007/s00228-020-03005-9 pubmed: 33025080
Sim DW, Yu JE, Jeong J et al (2019) Variation of clinical manifestations according to culprit drugs in DRESS syndrome. Pharmacoepidemiol Drug Saf 28(6):840–848. https://doi.org/10.1002/pds.4774
doi: 10.1002/pds.4774 pubmed: 31044478

Auteurs

Ahmed Hussein (A)

The Ohio State University College of Medicine, Columbus, OH, USA.

Kateri L Schoettinger (KL)

The Ohio State University College of Medicine, Columbus, OH, USA.

Jourdan Hydol-Smith (J)

Texas A&M School of Medicine, Bryan, TX, USA.

Kristopher Fisher (K)

Department of Dermatology, The Ohio State University Wexner Medical Center, 540 Officenter Place, Suite 240, Columbus, OH, 43230, USA.

Rachel M Kirven (RM)

Department of Dermatology, The Ohio State University Wexner Medical Center, 540 Officenter Place, Suite 240, Columbus, OH, 43230, USA.

Benjamin H Kaffenberger (BH)

Department of Dermatology, The Ohio State University Wexner Medical Center, 540 Officenter Place, Suite 240, Columbus, OH, 43230, USA.

Abraham M Korman (AM)

Department of Dermatology, The Ohio State University Wexner Medical Center, 540 Officenter Place, Suite 240, Columbus, OH, 43230, USA. Abraham.Korman@osumc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH